The Mean Corrected TIMI Frame Count Could Predict Major Adverse Cardiovascular Events in Patients with Coronary

Esra Poyraz1, Göktuğ Savaş1, Aysun Erdem1

  • 1Department of Cardiology, University of Health Sciences, Dr. Siyami Ersek Thoracic and Cardiovascular Training and Research Hospital, İstanbul, Turkey.

Insights

Higher mean corrected thrombolysis in myocardial frame count (TFC) is linked to increased major adverse cardiovascular events in patients with coronary slow-flow phenomenon. This finding highlights TFC as a potential predictor for adverse cardiovascular outcomes in this patient group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Imaging

Background:

  • Coronary slow-flow phenomenon (CSFP) is a condition characterized by delayed contrast agent transit in epicardial coronary arteries.
  • The clinical significance of CSFP and its association with adverse cardiovascular events require further elucidation.
  • Thrombolysis in myocardial infarction (TIMI) frame count is a quantitative measure of coronary blood flow, with corrected TIMI frame count (cTFC) offering improved accuracy.

Purpose of the Study:

  • To investigate the association between mean corrected thrombolysis in myocardial frame count (cTFC) and major adverse cardiovascular events (MACE) in patients diagnosed with coronary slow-flow phenomenon.
  • To identify predictors of recurrent chest pain and MACE in this patient cohort.

Main Methods:

  • A retrospective analysis of 98 patients with CSFP from 2015-2020.
  • Patients were stratified into quartiles based on their mean cTFC values.
  • Group 1 (higher cTFC, >36.68) was compared with Group 2 (lower cTFC, ≤36.68) regarding mortality and non-fatal cardiovascular complications.

Main Results:

  • Mean follow-up was 3.93 years. Group 1 showed significantly higher rates of recurrent chest pain and MACE compared to Group 2 (P ≤ .001 for both).
  • Independent predictors of recurrent chest pain included hypertension, hyperlipidemia, and mean cTFC.
  • Mean cTFC was identified as an independent predictor of MACE (OR 1.161, P = .021), alongside older age, hypertension, and hyperlipidemia.

Conclusions:

  • Elevated mean corrected thrombolysis in myocardial frame count is a significant predictor of major adverse cardiovascular events in patients with coronary slow-flow phenomenon.
  • Mean cTFC serves as a valuable quantitative marker for risk stratification in patients with CSFP.
Abstract